Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Clinical trial NCT05060237 · COMPLETED
Trial details
- NCT number
- NCT05060237
- Sponsor
- Biofrontera Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-04-20
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.